INVIVYD
Live / Registered — Registered (as of 11 Mar 2025)
What this means for you
Registered since 11 Mar 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Mar 2031: the §8 declaration of use).
Record
- Serial number
- 97568176
- Registration number
- 7724659
- Mark type
- Stylized text
- Filed
- 28 Aug 2022
- Published for opposition
- 11 Apr 2023
- Registered
- 11 Mar 2025
- Next maintenance filing
- §8 declaration of use, due by 11 Mar 2031 (grace period to 11 Sept 2031)
- Attorney of record
- James J. Saul
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development relating to pharmaceutical preparations and substances for the treatment and prevention of viral respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals for the treatment and prevention of viral respiratory diseases
Owner
- INVIVYD, INC., New Haven, CT, US
- INVIVYD, INC., Waltham, MA, US
- Adagio Therapeutics, Inc., Waltham, MA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 97568176 — Clementia Pharmaceuticals Inc. v. Adagio Therapeutics, Inc., filed 04 May 2023 (Terminated)
Prosecution history
- 30 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2024 — NON-FINAL ACTION E-MAILED
- 05 Nov 2024 — SU - NON-FINAL ACTION - WRITTEN
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED